ArticleClinical journal of gastroenterology2022
Multimodal therapy with aggressive hepatectomy, everolimus, and octreotide for metastatic pancreatic neuroendocrine neoplasm enables 10-year survival.
Shinsei Yumoto et al.PubMed ↗Publisher ↗
No numbers read from the abstract.